Quest Diagnostics

YTD

ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell DGX and other ETFs, options, and stocks.

About DGX

Quest Diagnostics, Inc. engages in the provision of diagnostic testing, information, and services. It operates through the Diagnostic Information Services (DIS) and All Other segments.

CEO

James E. Davis

CEOJames E. Davis

Employees

57,000

Employees57,000

Headquarters

Secaucus, New Jersey

HeadquartersSecaucus, New Jersey

Founded

1967

Founded1967

Employees

57,000

Employees57,000

DGX Key Statistics

Market cap

21.94B

Market cap21.94B

Price-Earnings ratio

22.98

Price-Earnings ratio22.98

Dividend yield

1.59%

Dividend yield1.59%

Average volume

784.41K

Average volume784.41K

High today

$205.00

High today$205.00

Low today

$199.09

Low today$199.09

Open price

$203.40

Open price$203.40

Volume

637.52K

Volume637.52K

52 Week high

$213.50

52 Week high$213.50

52 Week low

$157.20

52 Week low$157.20

Stock Snapshot

The current Quest Diagnostics(DGX) stock price is $199.70, with a market capitalization of 21.94B. The stock trades at a price-to-earnings (P/E) ratio of 22.98 and offers a dividend yield of 1.6%.

As of 2026-03-13, Quest Diagnostics(DGX) stock has fluctuated between $199.09 and $205.00. The current price stands at $199.70, placing the stock +0.3% above today's low and -2.6% off the high.

Quest Diagnostics(DGX) shares are trading with a volume of 637.52K, against a daily average of 784.41K.

During the past year, Quest Diagnostics(DGX) stock moved between $157.20 at its lowest and $213.50 at its peak.

DGX News

TipRanks 1d

Quest Diagnostics Adds Veteran Healthcare Leader to Board

Quest Diagnostics ( (DGX) ) just unveiled an announcement. On March 9, 2026, Quest Diagnostics’ board elected Timothy Wentworth, former CEO of Walgreens Boots...

TipRanks 1d

Quest Diagnostics elects Timothy Wentworth to Board of Directors

Quest Diagnostics (DGX) has elected Timothy Wentworth to serve as a director. Including Wentworth, the company’s board has eleven members. Wentworth was most re...

Simply Wall St 3d

Quest Diagnostics Expands Preventive Reach With Shield Colorectal Blood Test

Quest Diagnostics (NYSE:DGX) has partnered with Guardant Health to offer the FDA approved Shield blood test for colorectal cancer screening. The agreement will...

Analyst ratings

50%

of 22 ratings

Buy

45.5%

Hold

50%

Sell

4.5%

More DGX News

Nasdaq 4d

Should You Continue to Hold DGX Stock in Your Portfolio?

Quest Diagnostics DGX is well-poised to grow in the coming quarters owing to its investments in advanced diagnostics to deliver and scale innovative services. T...

Simply Wall St 5d

A Look At Quest Diagnostics Valuation After Recent Share Price Momentum

Advertisement Why Quest Diagnostics Stock Is on Investors’ Radar Quest Diagnostics (DGX) is back in focus after recent trading, with the share price last clos...

People also own

Based on the portfolios of people who own DGX. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.